Oral S-1 with 24-h Infusion of Irinotecan plus Bevacizumab versus FOLFIRI plus Bevacizumab as First-Line Chemotherapy for Metastatic Colorectal Cancer: An Open-Label Randomized Phase II Trial

類似資料

• Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer
  著者:: Ogimi, Takashi, 等
  出版事項: (2019)
• Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer
  著者:: Saito, Gota, 等
  出版事項: (2018)
• The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer
  著者:: Okada, Kazutake, 等
  出版事項: (2018)
• Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer
  著者:: Suzuki, Toshiyuki, 等
  出版事項: (2018)
• Risk scores as useful predictors of perioperative complications in patients with rectal cancer who received radical surgery
  著者:: Miyakita, Hiroshi, 等
  出版事項: (2016)